Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)
CNY 22.22
(0.63%)
CNY 22.22
(0.63%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 422.38 Million CNY | -2.34% |
| 2022 | 432.5 Million CNY | -1.88% |
| 2021 | 440.8 Million CNY | 17.81% |
| 2020 | 374.18 Million CNY | 7.72% |
| 2019 | 347.36 Million CNY | 2.18% |
| 2018 | 339.95 Million CNY | 45.71% |
| 2017 | 233.31 Million CNY | 21.92% |
| 2016 | 191.36 Million CNY | 5.68% |
| 2015 | 181.08 Million CNY | 16.51% |
| 2014 | 155.42 Million CNY | 44.75% |
| 2013 | 107.37 Million CNY | 55.71% |
| 2012 | 68.95 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 86.61 Million CNY | -27.67% |
| 2024 Q1 | 119.75 Million CNY | 23.42% |
| 2024 Q3 | 79.7 Million CNY | -13.09% |
| 2023 Q4 | 97.02 Million CNY | -0.78% |
| 2023 Q3 | 97.78 Million CNY | -10.63% |
| 2023 FY | 422.38 Million CNY | -2.34% |
| 2023 Q1 | 118.14 Million CNY | 1.18% |
| 2023 Q2 | 109.42 Million CNY | -7.38% |
| 2022 Q4 | 116.76 Million CNY | 25.07% |
| 2022 Q2 | 102.17 Million CNY | -15.0% |
| 2022 Q1 | 120.2 Million CNY | 2.81% |
| 2022 FY | 432.5 Million CNY | -1.88% |
| 2022 Q3 | 93.35 Million CNY | -8.63% |
| 2021 Q3 | 109.93 Million CNY | 2.96% |
| 2021 Q4 | 116.91 Million CNY | 6.35% |
| 2021 Q1 | 107.18 Million CNY | -7.7% |
| 2021 Q2 | 106.76 Million CNY | -0.39% |
| 2021 FY | 440.8 Million CNY | 17.81% |
| 2020 Q2 | 81.99 Million CNY | 5.89% |
| 2020 Q3 | 98.61 Million CNY | 20.28% |
| 2020 FY | 374.18 Million CNY | 7.72% |
| 2020 Q4 | 116.13 Million CNY | 17.76% |
| 2020 Q1 | 77.43 Million CNY | -26.07% |
| 2019 Q3 | 65.46 Million CNY | -15.23% |
| 2019 FY | 347.36 Million CNY | 2.18% |
| 2019 Q4 | 104.74 Million CNY | 60.01% |
| 2019 Q2 | 77.22 Million CNY | -22.73% |
| 2019 Q1 | 99.93 Million CNY | -11.06% |
| 2018 Q1 | 75.99 Million CNY | -6.87% |
| 2018 FY | 339.95 Million CNY | 45.71% |
| 2018 Q4 | 112.36 Million CNY | 45.7% |
| 2018 Q3 | 77.11 Million CNY | 3.55% |
| 2018 Q2 | 74.47 Million CNY | -2.01% |
| 2017 FY | 233.31 Million CNY | 21.92% |
| 2017 Q1 | 50.01 Million CNY | -9.5% |
| 2017 Q2 | 53.36 Million CNY | 6.71% |
| 2017 Q3 | 48.33 Million CNY | -9.43% |
| 2017 Q4 | 81.6 Million CNY | 68.85% |
| 2016 Q1 | 49.4 Million CNY | 0.0% |
| 2016 Q4 | 55.25 Million CNY | 27.06% |
| 2016 FY | 191.36 Million CNY | 5.68% |
| 2016 Q3 | 43.49 Million CNY | 0.64% |
| 2016 Q2 | 43.21 Million CNY | -12.53% |
| 2015 FY | 181.08 Million CNY | 16.51% |
| 2014 FY | 155.42 Million CNY | 44.75% |
| 2013 FY | 107.37 Million CNY | 55.71% |
| 2012 FY | 68.95 Million CNY | 0.0% |